BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10229324)

  • 21. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
    Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
    Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells.
    Lundin Brockdorff J; Woetmann A; Mustelin T; Kaltoft K; Zhang Q; Wasik MA; Röpke C; Ødum N
    Cytokine; 2002 Nov; 20(4):141-7. PubMed ID: 12543077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15.
    Campbell JD; Cook G; Robertson SE; Fraser A; Boyd KS; Gracie JA; Franklin IM
    J Immunol; 2001 Jul; 167(1):553-61. PubMed ID: 11418694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression.
    Collins ND; D'Souza C; Albrecht B; Robek MD; Ratner L; Ding W; Green PL; Lairmore MD
    J Virol; 1999 Nov; 73(11):9642-9. PubMed ID: 10516077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
    Bianchi M; Meng C; Ivashkiv LB
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.
    Liu RY; Fan C; Garcia R; Jove R; Zuckerman KS
    Blood; 1999 Apr; 93(7):2369-79. PubMed ID: 10090948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.
    Beadling C; Guschin D; Witthuhn BA; Ziemiecki A; Ihle JN; Kerr IM; Cantrell DA
    EMBO J; 1994 Dec; 13(23):5605-15. PubMed ID: 7988557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.
    Nicot C; Mulloy JC; Ferrari MG; Johnson JM; Fu K; Fukumoto R; Trovato R; Fullen J; Leonard WJ; Franchini G
    Blood; 2001 Aug; 98(3):823-9. PubMed ID: 11468184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
    Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
    J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal.
    Migone TS; Humbert M; Rascle A; Sanden D; D'Andrea A; Johnston JA
    Blood; 2001 Sep; 98(6):1935-41. PubMed ID: 11535532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway.
    Kilic M; Flossmann E; Flossmann O; Vogelsang H; Junker U; Chaouat G; Markert UR
    Am J Reprod Immunol; 1999 Jan; 41(1):61-9. PubMed ID: 10097788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.
    Adachi M; Ishino M; Torigoe T; Minami Y; Matozaki T; Miyazaki T; Taniguchi T; Hinoda Y; Imai K
    Oncogene; 1997 Apr; 14(13):1629-33. PubMed ID: 9129156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
    Bright JJ; Kerr LD; Sriram S
    J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines.
    Samaan A; Mahana W
    Immunol Lett; 2007 Apr; 109(2):113-9. PubMed ID: 17368812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM; Hawley TS; Hawley RG; Qu CK
    Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
    Liu J; Kern JA
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.